• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    OptimizeRx Corporation - Common Stock (NQ:OPRX)

    5.430 +0.310 (+6.05%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 358,303
    Open 5.160
    Bid (Size) 4.780 (200)
    Ask (Size) 5.580 (1,000)
    Prev. Close 5.120
    Today's Range 5.115 - 5.560
    52wk Range 4.540 - 22.25
    Shares Outstanding 17,618,607
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
    Patent-pending, embeddable NLAB technology enables pharma and agency marketers to build custom, verified HCP audiences using natural-language prompts 
    From OptimizeRx Corporation
    Via GlobeNewswire
    MissionIRNewsBreaks – OptimizeRx Corp. (NASDAQ: OPRX) Secures $35 Million Senior Credit Facility
    Via Investor Brand Network
    Topics Artificial Intelligence

    Performance

    YTD
    -56.3%
    -56.3%
    1 Month
    +4.6%
    +4.6%
    3 Month
    -15.9%
    -15.9%
    6 Month
    -55.7%
    -55.7%
    1 Year
    -59.8%
    -59.8%

    More News

    Read More
    News headline image
    OptimizeRx to Participate in Upcoming Investor Conferences
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
    From OptimizeRx Corporation
    Via GlobeNewswire
    OptimizeRx Corp (NASDAQ:OPRX) Beats Q1 Estimates But Slashes 2026 Revenue Guidance ↗
    Via Chartmill
    OptimizeRx Corp (NASDAQ:OPRX) Beats Q4 Earnings Estimates but Offers Cautious 2026 Outlook ↗
    Via Chartmill
    News headline image
    OptimizeRx (OPRX) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    OptimizeRx Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    Discover the top movers in Wednesday's pre-market session. ↗
    Via Chartmill
    News headline image
    OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    Whetstone Capital Exits GitLab as Enterprises Rethink AI-Driven Software Development Tools ↗
    Via The Motley Fool
    Topics Artificial Intelligence Regulatory Compliance
    News headline image
    Whetstone Dumps 79,000 monday.com Shares Worth $15.3 Million ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    Why One Fund Still Has a $14 Million Bet on This Resale Stock Up 130% This Past Year ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    BrightView Shares Down 30%: What a Full Fund Exit Signals for Investors ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why One Fund Added 415,000 Shares of a Software Stock Down 26% This Past Year ↗
    Via The Motley Fool
    News headline image
    This Fund Just Bought $6 Million in Plug Power Stock — Is a Turnaround in Sight? ↗
    Via The Motley Fool
    Topics Economy Regulatory Compliance

    Frequently Asked Questions

    Is OptimizeRx Corporation - Common Stock publicly traded?
    Yes, OptimizeRx Corporation - Common Stock is publicly traded.
    What exchange does OptimizeRx Corporation - Common Stock trade on?
    OptimizeRx Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for OptimizeRx Corporation - Common Stock?
    The ticker symbol for OptimizeRx Corporation - Common Stock is OPRX on the Nasdaq Stock Market
    What is the current price of OptimizeRx Corporation - Common Stock?
    The current price of OptimizeRx Corporation - Common Stock is 5.430
    When was OptimizeRx Corporation - Common Stock last traded?
    The last trade of OptimizeRx Corporation - Common Stock was at 06/29/26 04:00 PM ET
    What is the market capitalization of OptimizeRx Corporation - Common Stock?
    The market capitalization of OptimizeRx Corporation - Common Stock is 95.67M
    How many shares of OptimizeRx Corporation - Common Stock are outstanding?
    OptimizeRx Corporation - Common Stock has 96M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.